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Summary 
Anucleate cells can be induced to undergo programmed cell death (PCD), indicating the exist- 
ence of a cytoplasmic PCD pathway that functions independently from the nucleus. Cytoplas- 
mic structures including mitochondria have been shown to participate in the control of apop- 
totic nuclear disintegration. Before cells exhibit common signs of nuclear apoptosis (chromatin 
condensation and endonuclease-mediated DNA fragmentation), they undergo a reduction of 
the mitochondrial transmembrane potential (A~m) that may be due to the opening of mito- 
chondrial permeability transition (PT) pores. Here, we present direct evidence indicating that 
mitochondrial PT constitutes a critical early event of the apoptotic process. In a cell-free system 
combining purified mitochondria and nuclei, mitochondria undergoing PT suffice to induce 
chromatin condensation and DNA fragmentation. Induction of PT by pharmacological agents 
augments the apoptosis-inducing potential of mitochondria. In contrast, prevention of PT by 
pharmacological agents impedes  nuclear apoptosis,  both in vitro and in vivo. Mitochondria 
from hepatocytes or lymphoid cells undergoing apoptosis, but not those from normal cells, in- 
duce the disintegration of isolated Hela nuclei. A specific ligand of the mitochondrial adenine 
nucleotide translocator (ANT), bongkrekic acid, inhibits PT and reduces apoptosis induction 
by mitochondria in a cell-free system. Moreover, it inhibits the induction of apoptosis in intact 
cells. Several pieces of evidence suggest that the proto-oncogene product Bcl-2 inhibits apop- 
tosis by preventing mitochondrial PT. First,  to inhibit nuclear apoptosis, Bcl-2 must be local- 
ized in mitochondrial but not in nuclear membranes. Second, transfection-enforced hyperex- 
pression  of Bcl-2  directly  abolishes  the  induction  of mitochondrial  PT  in  response  to  a 
protonophore, a pro-oxidant, as well as to the ANT ligand atractyloside, correlating with its 
apoptosis-inhibitory effect. In conclusion, mitochondrial PT appears to be a critical step of the 
apoptotic cascade. 
S 
ince it has been shown that anucleate cells  (cytoblasts) 
can  be  induced  to  undergo  programmed  cell  death 
(PCD) 1 (1-3), it has become clear that a cytoplasmic PCD 
pathway  must  function  independently from the  nucleus. 
Both  mitochondria  (4)  and  specific  ced-3-1ike  proteases 
1Abbreviations used in  this paper: ANT, adenine nucleotide translocator; 
Atr, atractyloside;  BA, bongkrekic  acid; CsA, cyclosporin  A; DAPI, 4'-6- 
diamidino-2-phenylindole dihydrochloride;  DEX, dexamethasone; dia- 
mide, diazenedicarboxylic acid his  5N,  N-dimethylamide; DiOC6(3), 
3,3'dihexyloxacarbocyanine  iodide; Aq~m, mitochondrial  transmembrane 
potential; GAIN, D-galactosamine;  ICE, IL-113  converting  enzyme;  MCB, 
monochlorobimane; mCICCP, carbonyl  cyanide m-chlorophenylhydra- 
zone; mtDNA, mitochondrial  DNA; PCD, programmed  cell death; PT, 
permeability transition; P,  OS, reactive oxygen species; R.tL, ruthenium 
red; ter-BHP, ter-butylhydroperoxide. 
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(5-7) have been accused of participating in the cytoplasmic 
control of apoptotic nuclear disintegration. We and others 
(8-12) have recently demonstrated that cells undergo a re- 
duction  of  the  mitochondrial  transmembrane  potential 
(A~m) before they exhibit common signs of nuclear apop- 
tosis  (chromatin condensation and endonuclease-mediated 
DNA  fragmentation).  This  applies  to  different cell  types 
(neurons, fibroblasts, B and T lymphocytes, pre-B cells and 
thymocytes, myelomonocytic cells) and to different physio- 
logical apoptosis inducers (growth factor withdrawal, tumor 
necrosis factor, ceramide, glucocorticoids, activation-induced 
cell death, positive and negative selection, irradiation; 8-13). 
Moreover, these observations extend to pathogen-induced 
apoptosis,  including  irradiation-induced  PCD  (13)  and 
HIV-l-triggered T  lymphocyte PCD  (14). When PCD is 
prevented either by genetic manipulations  (e.g.,  p53  loss 
mutation,  bcl-2  hyperexpression)  or  by  pharmacological 
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mitochondrial  and nuclear signs of apoptosis are abolished 
(10,  12,  13). Moreover, cells  that have lost their  Axlr m  ap- 
pear to be irreversibly programmed to die  (10).  Although 
these  observations  suggest  the  involvement  of mitochon- 
dria in apoptosis,  they do not clarify the cause-effect rela- 
tionship between mitochondrial dysfunction and subsequent 
nuclear apoptosis. It appears clear that reactive oxygen spe- 
cies (ROS),  which may be generated by uncoupled mito- 
chondria (9,  12), are not essential for the apoptotic process 
(15-17). Thus, whenever a cause-effect relationship between 
mitochondrial disorders and nuclear apoptosis exists,  it must 
be mediated  by factors other than  ROS.  The  aim  of this 
paper was to unravel the existence of such a pathway link- 
ing mitochondrial dysfunction to nuclear disintegration. 
As to the mechanism ofapoptotic Axlt  m disruption, phar- 
macological experiments suggest that it involves the open- 
ing of so-called mitochondrial permeability transition  (PT) 
pores  (12,  18).  Under normal conditions,  the inner mito- 
chondrial membrane is quasi-impermeable  for small mole- 
cules, thus allowing for the creation of the electrochenfical 
gradient which is indispensable for mitochondrial function. 
However,  in  determined  circumstances,  opening  of PT 
pores or "megachannels" allows for the free distribution of 
solutes  of <1,500  daltons  and  of some  proteins,  thereby 
disrupting the  A~tI't  m  and associated mitochondrial functions 
(19,  20).  In isolated mitochondria,  PT is  accompanied by 
colloidosmotic swelling and uncoupling of oxidative phos- 
phorylation, as well as by the loss of low molecular weight 
matrix molecules such as calcium and glutathione  (19-21). 
It may be important to note that PT is modulated by mul- 
tiple  different  physiological and  pharmacological  inducers 
and inhibitors (for a review see reference 22) and that PT is 
both the cause and the consequence of AW  m dissipation, as 
well as of reactive  oxygen metabolite production  (19-29). 
In other terms, PT results ipso facto in A~ m disruption and 
later  in  ROS  hyperproduction,  but  AXlt  m  reduction  and 
ROS  themselves  can also  provoke PT,  as  do many other 
factors (divalent cations, pH variations, peptides,  etc; 22). 
The exact molecular composition of the PT pore is not 
known.  However,  it appears  that at least  one inner mito- 
chondrial transmembrane protein,  namely the adenine nu- 
cleotide translocator (ANT), is involved in PT pore forma- 
tion  (for  reviews  see  references  19,  20)  and  that  ANT 
associates  with  several  molecules  of the  outer  mitochon- 
drial  membrane such as  the peripheral  benzodiazepine  re- 
ceptor  and  the  voltage-dependent  anion  channel  (30). 
ANT  ligands  such  as  atractyloside  (Atr)  and  bongkrekic 
acid (BA) enhance or reduce the probability of PT, respec- 
tively (31-35). 
Based on these  premises,  we have tested  the hypothesis 
that PT might be the critical event determining the apop- 
tosis-inducing potential of mitochondria. Using a cell- and 
cytosol-free  system  in  which  purified  mitochondria  and 
nuclei  are  confronted,  we  show  that  induction  of PT  by 
the  ANT  ligand  Atr  or  other  less  specific  PT  inducers 
causes isolated mitochondria to trigger nuclear apoptosis. In 
contrast, inhibition of PT by the Atr antagonist BA, as well 
as by a variety of additional  PT inhibitors,  abolishes mito- 
chondria-mediated nuclear apoptosis. The apoptosis-inhib- 
itory proto-oncogene product Bcl-2 functions as an endog- 
enous inhibitor  of mitochondrial  PT.  These  data  establish 
mitochondrial PT as a critical event of apoptosis. 
Materials  and Methods 
Animals and In  Vivo Treatments.  Male  6--10-wk-old BALB/c 
mice were injected simultaneously  with D-galactosamine  (GAIN; 
10 mg i.p.) and/or LPS from Escherichia coli (Signa Chemical Co., 
St. Louis, MO; 50 btg i.v.),  5 h before removal of the liver (36). 
Alternatively, splenocytes were recovered from BALB/c mice 12 h 
after injection of 1 mg i.p.  dexamethasone (DEX; Sigma Chemi- 
cal Co.) in 200 btl PBS or PBS alone (10, 37). 
Cell Lines and In  Vitro Culture Conditions.  U937 cells were de- 
pleted from mitochondrial DNA (mtDNA) by continuous ethid- 
ium bromide selection for 4 mo (15). Control experiments  re- 
vealed  that  such  cells become resistant  to  antimycin A,  which 
blocks the mtDNA-encoded complex III. Moreover, no mtDNA 
could be detected by PCP,.  (not shown). 2B4.11  T  cell hybrid- 
oma cell lines  stably transfected  with  an SFFV.neo vector con- 
taining the human bcl-2 gene or the neomycin (Neo) resistance 
gene  only (38,  39)  were kindly provided by Jonathan Ashwell 
(National Institutes  of Health,  Bethesda,  MD).  Cells  were  cul- 
tured in RPMI-1640 medium containing 5% FCS. Apoptosis was 
induced by culturing cells in the presence of the indicated con- 
centration ofdiazenedicarboxylic  acid bis 5N, N-dimethylamide  (dia- 
mide)  or carbonyl cyanide m-chlorophenylhydrazone (mC1CCP; 
both from Sigma Chemical Co.). DNA fragmentation of non- or 
",/-irradiated (10  Gy)  thymocytes (106 cells/lane)  was monitored 
after culturing cells for 4 h in the presence of DEX (1 I~M), eto- 
poside  (10 ~M; Sigma Chemical Co.), and/or BA (50 btM; puri- 
fied as described  in reference  40),  kindly provided by Dr. J.A. 
Duine (Delft University,  Delft,  The Netherlands). 
Cell-free System of  Apoptosis.  Nuclei  from  HeLa  or  2B4.11 
cells were purified on a sucrose  gradient,  as described  (41), and 
were resuspended  in CFS buffer (220 nM mannitol, 68 mM su- 
crose,  2 mM NaC1,  2.5 mM PO4H2K,  0.5  mM EGTA, 2 mM 
C12Mg  , 5 mM pyruvate, 0.1 mM PMSF, 2 mM ATP, 50 Ixg/nfl 
creatine  phosphokinase,  10 mM phosphocreatine,  1 mM dithio- 
threitol,  and 10 mM Hepes-NaOH, pH 7.4; reagents from Sigma 
Chemical Co.). Nuclei were conserved at -20~  in 50% glycerol 
for up to 8 d as described  (41, 42).  Mitochondria were purified 
from BALB/c mouse livers, splenocytes,  or U937 cells on a Per- 
coll gradient  (43) and were stored on ice in B buffer (400 mM 
mannitol,  10 mM  PO4H2K,  5 mg/ml BSA,  and  50  mM Ttis- 
HC1, pH 7.2) for up to 4 h. For quantitation of nuclear apoptosis, 
both nuclei (5,000g, 5 rain) and mitochondria (2 ￿  104g, 3 min) 
were spun down and washed twice in CFS buffer before being 
mixed. In standard  conditions, mitochondria (500 ng/~l protein 
final concentration) were cultured at 37~  for 90 min with  103 
nuclei per ~1 CFS containing a number of different  agents: AIF3, 
(20 p,M), Atr (5 raM; Sigma Chemical Co.), BA (50 ~M), CaC12 
(500 I.zM), mC1CCP (10 p~M), diamide (100 p,M), cyclosporin A 
(CsA,  10 /a,M; Sandoz AG, Basel, Switzerland),  N-methylVal-4- 
CsA  (SDZ  220-384,  10  btM;  kindly provided by Dr.  Roland 
Wenger,  Sandoz),  monochlorobimane  (MCB;  30  p~M), phos- 
photyrosine (P;  10 raM),  ruthenium red (RR,  100 ~M;  Sigma 
Chemical Co.), ter-butylhydroperoxide  (ter-BHP, 50 btM; Sigma 
Chelnical Co.), ZnC12 (1 raM), AcYVAD-CHO (IL-1]3 convert- 
ing  enzyme  [ICE]  inhibitor  I),  AcYVAD-chloromethylketone 
(ICE inhibitor II), and/or AcDEVD-CHO (inhibitor of CPP32/ 
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with 4'-6-diamidino-2-phenylindole  dihydrochloride (DAPI; 10 
~M) and examined by fluorescence  microscopy (5), or were ana- 
lyzed by agarose gel electrophoresis (106 nuclei/lane) (44). 
Cytofluorometric Analysis.  For AxI/m  determinations,  isolated mi- 
tochondria were incubated for 15 rain at 37~  in the presence of 
DiOC6(3  )  (80 riM)  (45), followed by addition of mC1CCP (50 
p~M), BA (50 I~M) and/or Atr (5 raM), and recording of the flu- 
orescence  in an Elite cytofluorometer (Coulter Corp.,  Hialeah, 
FL)  5 rain later.  Loss of nuclear DNA (hypoploidy)  was deter- 
mined by propidium iodine staining of ethanol-fixed cells, as de- 
scribed (46). 
Large Amplitude Swelling of Isolated Mitochondria.  Large  ampli- 
tude swelling is a colloidosmotic process that is observed among 
isolated mitochondria undergoing PT in solutions containing  low 
protein concentrations (22). For determination of swelling, mito- 
chondria were washed and resuspended in B buffer (100 ~g pro- 
tein/10 ~1 buffer),  followed by addition of 90 p~M CFS buffer 
and recording of adsorption at 540  nm in a spectrophotometer 
(model DU 7400; Beckman Instruments, Inc., Fullerton, CA), as 
described  (26). The  loss of absorption induced by  5  mM  Atr 
within 5 rain was considered 100% the value of large amplitude 
swelling. 
Characterization of Factors Contained in  the Supernatant of Mito- 
chondria.  Hepatic mitochondria (1  mg/ml in CFS buffer)  were 
left untreated or were incubated with Atr (5 raM) for 10 rain at 
room temperature, followed by ultracentrifugation (1.5  ￿  10  s g, 
30 rain, 4~  Supernatants were either left untreated or centri- 
fuged through a Centricon 10 membrane (Amicon Inc., Beverly, 
MA) to separate proteins with an approximate molecular mass of 
>  and <10 kD, following the manufacturers' recommendation. 
The fraction >10 kD was reconstituted with CFS to the original 
volume.  Supematants  (50% volume)  were  mixed  with  nuclei 
(103/~1) in the presence or absence  of various antioxidants (50 
p~M N-t-butyl-ot-phenylnitrone,  230 ~M trolox, 600 IxM L-ascor- 
bate, or 1 mg/ml catalase; Sigma Chemical Co.), and nuclei were 
stained with DAPI after 90 min of culture at 37~ 
Results  and Discussion 
Isolated Mitochondria  Undergoing PT Induce Nuclear Apopto- 
sis in a Cell-free  System.  One of the  PT pore  constituents 
is the ANT. The ANT adopts different molecular confor- 
mations when exposed to two specific ligands, Atr and BA 
(31,  47).  Atr favors the  opening of the PT pore, whereas 
BA reduces the probability of PT pore gating (31-35, 47). 
We have tested the capacity of purified mitochondria with 
open and closed PT pores to induce nuclear apoptosis in a 
modified cell-free system (4, 42). Mitochondria were puri- 
fied from the murine liver and were mixed with Hela nu- 
clei in an isotonic buffer containing an ATP regeneration 
system.  On  their  own,  unmanipulated mitochondria de- 
rived from healthy cells are incapable of inducing signs of 
nuclear apoptosis such as chromatin condensation and en- 
donuclease-mediated DNA fragmentation. However,  mi- 
tochondria exposed to a dose of Atr that causes PT, deter- 
mined either as  large  amplitude swelling (Fig.  1 A)  or as 
disruption of the  AXI~  m  (Fig 1 B),  do induce nuclear apop- 
tosis (Fig. 1 C) in a time- and dose-dependent fashion (Fig. 
1 D). Atr does not induce apoptosis itsel~ it only favors the 
induction  of  nuclear  apoptosis  when  mitochondria  are 
present (Fig. 1 C). In the presence ofBA, mitochondria fail 
to undergo PT in response to Atr (Fig. 1, A and B) and lose 
the  capacity to induce chromatin condensation (Fig.  1  C) 
and associated oligonucleosomal DNA fragmentation (Fig. 
Figure !.  Regulation of mito- 
chondrial PT and mitochondria- 
mediated nuclear apoptosis by 
two adenine nucleotide translo- 
cator ligands. (A) Effect of atrac- 
tyloside  (Atr) and  bongkrekic 
acid (BA) on mitochondrial  large 
amplitude  swelling.  (Arrows) 
Time  points at  which BA  (50 
p~M) and/or  Atr (5  mM)  were 
added to mitochondria. (B) A~,,, 
of Atr-  and  BA-treated mito- 
chondria, as  determined by in- 
corporation  of  DiOC6(3  )  into 
mitochondria, 5 rain after addi- 
tion of Atr and/or BA. Incuba- 
tion  with  the  protonophor 
mC1CCP, which completely  dis- 
rupts  the  A~  m,  unravels 
DiOC6(3)  background fluores- 
cence. (C)  Chromatin distribu- 
tion of isolated HeLa nuclei cul- 
tured  with  mitochondria, Atr, 
and/or BA for  90  rain.  Single 
nuclei stained with DAPI repre- 
senting the dominant phenotype 
(I>80%) are shown. (D) Time and dose dependence of nuclear chromatin condensation.  Nuclei were incubated during the indicated interval with the 
specified amount of mitochondria (doses in I~g protein) and/or Atr. (E) Fragmentation  of nuclear DNA induced by mitochondria. Purified HeLa nuclei 
were cocultured  with mitochondria (500 ng/~tl), Atr, and/or BA for 90 min (same conditions  as in C), followed  by agarose gel electrophoresis of ethid- 
ium bromide-stained DNA. Lane I: Atr only; lane 2: mitochondria  only; lane 3: mitochondria  plus Atr; and lane 4: mitochondria  plus Atr Flus BA. 
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inducing capacity ofmitochondria. 
Mitochondria Lacking mtDNA  Can  Undergo PT and Cause 
Nuclear Apoptosis in a Cell-free System.  Although  most  pro- 
teins  contained  in  mitochondria  are  encoded  by  nuclear 
genes, a number of proteins including some components of 
the respiratory chain complexes I, III, and IV, are encoded 
by the mitochondrial genome. Previously, it has been re- 
ported  that  cell lines  lacking mtDNA  can  undergo  full- 
blown nuclear apoptosis  (15),  and this finding could give 
rise to the interpretation that mitochondria are not impor- 
tant for the control ofapoptosis. To challenge this (over)in- 
terpretation, we purified mitochondria from cells  lacking 
mtDNA  (po cells),  as  well  as  from  control p+  cells,  and 
tested their apoptosis-inducing potential. As shown in Fig. 
2 A, pO mitochondria can undergo large amplitude swelling 
in  response  to  Atr,  exactly as  do  p+  control  organelles. 
Moreover, in the presence of Atr,  pO mitochondria are as 
efficient inducers of nuclear disintegration,  as  are control 
p+  mitochondria  (Fig.  2  B).  This indicates that all mito- 
chondrial functions critical for apoptosis induction are en- 
coded by nuclear genes. Thus, in accord with the published 
data  (15),  the capacity of mitochondria to induce nuclear 
apoptosis  does  not  depend  on  the  presence  of mtDNA. 
Furthermore,  the  fact  that  respiration-deficient po  mito- 
chondria  (which  may be  expected to  produce less  ROS 
than p+ control organelles) conserve their proapoptotic ac- 
tivity, suggests  that ROS do not mediate apoptosis in this 
cell-free system. 
Strict Correlation Between PT-associated Swelling and Nuclear 
Apoptosis Induction.  The above results suggest that  mito- 
chondria are indeed efficient inducers of nuclear apoptosis, 
provided that they are undergoing PT. This conclusion is 
corroborated by the strict correlation between PT and the 
proapoptotic effect of mitochondria, when PT is induced 
by a variety of different molecules: Atr, the pro-oxidant ter- 
BHP, and calcium ions via the thiol-cross-linking agent di- 
amide or the protonophore mC1CCP (Fig.3).  All these re- 
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Figure 2.  Mitochondrial  swelling and nuclear apoptosis induction do 
not require mitochondrial  DNA. (A) Large amplitude swelling of mito- 
chondria lacking mtDNA. Mitochondria obtained from normal U937 
cells (p§  or U937 cells  lacking  mtDNA (pC) were incubated while assess- 
ing absorbance  at 540 nM. (Arrow)  Addition of  Atr (5 mM). (B) Induction 
of  nuclear apoptosis by mitochondria  lacking mtDNA. HeLa nuclei were 
cultured for 90 rain with Atr and/or mitochondria  obtained from p+ or 
po U937 cells, followed  by determination  of  the frequency  ofapoptotic  or 
damaged nuclei. 
agents are thought to act via distinct mechanisms:  Atr by 
virtue of  its capacity to interact with the ANT (31-35); cal- 
cium  via  conformational effects on  proteins  that  are  yet 
poorly understood (19,  20, 22); hydroperoxides via oxida- 
tion of mitochondral glutathione and pyridine nucleotides 
(48);  diamide  via  its  thiol-cross-linking  action  on  the 
ANT(49,  50);  and  protonophores  via  dissipation  of the 
proton gradient  (A~m),  then entailing PT as  a secondary 
phenomenon  (24,  27,  28).  Control  experiments indicate 
that none of these reagents induces nuclear apoptosis by it- 
self, i.e., in the absence ofmitochondria (not shown). Atr- 
induced swelling and nuclear apoptosis  are efficiently in- 
hibited  by BA  and  CsA,  as  well  as  by the  thiol  reagent 
MCB.  CsA can be substituted for by the nonimmunosup- 
pressive CsA  analogue N-methylVal-4-CsA  (51),  indicat- 
ing that its PT and apoptosis-inhibitory effect is not medi- 
ated  via  calcineurin.  A  series  of  substances  previously 
reported to inhibit apoptosis in a cell-free system (4)  can 
also  inhibit  both  PT  and mitochondria-mediated nuclear 
apoptosis:  phosphotyrosine, ZnC12, and A1F  3 (Fig. 3). Other 
substances (4) have no or little (<20%) inhibitory effects on 
Atr-induced swelling and apoptosis: calpain inhibitors I and 
1I,  GTPTS, and ionomycin. Similarly, synthetic tetrapep- 
tide inhibitors of ICE and of CPP32/Yama fail to interfere 
with  PT  and  PT-dependent nuclear apoptosis  (Table  1). 
Calcium-driven but not Atr-induced PT and apoptosis are 
selectively inhibited by RR, a specific inhibitor of the mi- 
tochondrial calcium uniport (52), underscoring the fact that 
proapoptotic calcium effects are indeed mediated by mito- 
chondria.  As  expected (50),  the  syn-9,10-dioxa-bimanine 
halogen derivative MCB is particularly effective in inhibit- 
ing PT and apoptosis induced by diamide  (Fig.  3).  In ac- 
cord with published data  (for a review see reference 22), 
none of the inhibitors used in this study is capable of pro- 
viding long-term (>30 rain) protection against  mitochon- 
drial swelling in response to the whole panel of PT induc- 
ers.  This probably reflects the profound differences in the 
molecular mechanisms of PT caused by different inducers 
(19, 20, 22, 24, 27, 28, 48-50). 
In synthesis, the strict correlation existing between mito- 
chondrial PT and mitochondria-mediated nuclear apoptosis 
suggests  that PT is indeed a crucial event in the regulation 
ofapoptosis induction by mitochondria. Moreover, the fact 
that  none  of the  inhibitory substances  (BA,  CsA,  MCB, 
RR, phosphotyrosine, ZuC12, A1F3) suppresses  PT and ap- 
optosis in response to all PT inducers (Fig. 3) suggests  that 
they do  not  directly affect nuclei  but  rather  act  via  PT 
modulation. Finally, the data summarized in Fig.  3 under- 
score the complex pharmacology ofmitochondrial PT. 
Mitochondria  fiom Cells Undergoing Apoptosis Transfer Nuclear 
Apoptosis to a Cell-free System.  According  to  several  studies 
(8-10,  12),  mitochondrial function is perturbed early dur- 
ing the apoptotic process. Accordingly, mitochondria iso- 
lated  from hepatocytes exposed in  vivo  to  an  apoptosis- 
inducing combination of GaIN and LPS (36,  53), but not 
control cells treated with GaIN or LPS only, display a re- 
duced uptake  of the  cationic lipophilic dye 3,3'  dihexyl- 
oxacarbocyanine iodide (DiOC6[3]) (Fig. 4 A), indicating a 
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Figure 3.  Correlation between mitochondrial swelling and mitochondrial induction of nuclear apoptosis. Mitochondria  from hepatocytes were incu- 
bated with the PT inducers Atr (5 re_M), ter-BHP (50 FtM), CaC12 (500 p,M), mCICCP (10 ~M), or diamide (100 ~M) and/or the PT inhibitors BA (50 
I~M), CsA (10p~M), N-methylVal-4-CsA  (SDZ; 10 I~M), MCB (30 ~M), or RR (100 ~M). Mitochondria were also incubated with P (10 mM), ZnC12 
(lmM), or AIF  3 (20 ~M). The percentage of condensed nuclei cocultured with mitochondria was recorded after 90 min of incubation at 37~  (open col- 
umns, X  +  SEM of triplicates). Large amplitude swelling was recorded after 5-90 min of culture (black columns). Data are shown for 60 rain, when the 
correlation between nuclear apoptosis and mitochondrial swelling is optimal. These results are representative of five independent experiments. 
decrease  of the  A~klf  m.  Such  mitochondria from  apoptotic 
liver cells cause nuclear apoptosis in vitro (Fig. 4  B). Simi- 
larly a fraction of mitochondria from splenocytes treated in 
vivo with  the  glucocorticoid analogue DEX  (10,  37)  dis- 
play a  reduced  A~ m (Fig.  5 A) and cause apoptosis of iso- 
lated  Hela  nuclei in vitro  (Fig.  5  B).  Thus,  mitochondria 
from  different cell types undergoing apoptosis  in vivo are 
endowed with the capacity of apoptosis induction in a ceU- 
free system. 
Inhibition of PT Inhibits Nuclear Apoptosis both  In  Vitro  and 
In  Vivo.  The  ANT  ligand  BA  is  the  agent  with  the 
broadest  PT-inhibitory  spectrum  among  all  substances 
tested thus far  (Figs.  1 and 3)  and is the only PT inhibitor 
that  is  truly  specific  for  a  mitochondrial  structure.  We 
Table 1.  Substances that Fail to Modulate PT and Mitochondria-dependent Nuclear Apoptosis 
Inhibition of 
Substance  Dose range  Inhibition of PT  nuclear apoptosis 
Calpain inhibitor I  100 heM-1 mM  None*  None 
Ca]pain inhibitor II  100 IxM-1 mM  None  None 
ICE inhibitor I  100 heM-500 p.M  None  None 
ICE inhibitor II  100 p~M-500 p.M  None  None 
AcDEVD-CHO  100 p~M-500 p~M  None  None 
GTP3~S  100 p~M-i mM  None  None 
Ionomycin  10 ~M-100 I-~M  None  None 
*The indicated substances were employed to modulate the induction of PT in isolated mitochondria induced by the following reagents: Atr,  ter- 
BHP, calcium, m-C1CCP, and diamide  (same conditions and concentrations as in Fig. 3). Absence of inhibition indicates  <20% suppression of ei- 
ther mitochondrial swelling (measured at 60 min as in Fig. 3) or nuclear condensation (measured at 90 rain in the same conditions as in Fig. 3), in re- 
sponse to all tested PT inducers. 
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Figure 6.  BA inhibits apopto- 
sis  of  thymocytes  induced  by 
various  stimuli. Murine  thy- 
mocytes were  exposed to DEX 
(1  I,M),  etoposide (10  IzM), or 
cultured  after  y-irradiation  (t0 
Gy) in the presence or absence of 
BA (50  }*M). DNA fragmenta- 
tion  of thymocytes  (106 cells/ 
lane) was monitored  after a 4-h 
culture period. Results are repre- 
sentative  of  three  independent 
experiments. 
Figure 4.  Mitochondria from apoptotic hepatocytes  cause nuclear apop- 
tosis in a cell-free system. (A) Reduction of the A~  m in mitochondria 
from cells  undergoing apoptosis  in vivo. Liver mitochondria were obtained 
from animals treated with  an apoptosis-inducing combination of GaIN 
and/or LPS, followed by DiOCt(3) labeling for A~tIf m  assessment.  (B) Mi- 
tochondria from apoptotic hepatocytes induce  nuclear apoptosis. After 
the indicated in vivo treatment,  liver mitochondria  were purified and 
added to HeLa nuclei in the presence or absence of BA (50 ~M),  fol- 
lowed by evaluation ofchromatin  condensation as in Fig. 1. Data are rep- 
resentative of  two independent experiments. 
therefore  tested  the  effect  of BA  on  the  mitochondria- 
mediated transfer of apoptosis from whole cells undergoing 
PCD  to the cell-free system. As shown in Figs. 4  A  and 5 
A,  BA  partially reduces  the  proapoptotic  effect  of mito- 
chondria from GalN/LPS-stimulated hepatocytes of DEX- 
primed splenocytes in  vitro.  This  inhibition is sigxtificant: 
48  +  10% for GalN/LPS-treated hepatocyte mitochondria 
and  44  +  9%  for DEX-primed  splenocyte mitochondria. 
In  addition,  BA  is  highly  efficient  (>90%  inhibition)  in 
preventing the death of intact thymocytes exposed to a se- 
ries of different apoptosis inducers:  DEX,  irradiation, and 
topoisomerase inhibition (Fig. 6). These results corroborate 
the  notion  that  mitochondria  are  indeed  involved in  the 
|'  I 
log DIOC6(3) 
Figure 5.  Transfer  of apoptosis by mitochondria from apoptotic sple- 
nocytes. (A) A~  m  disruption of mitochondria from DEX-primed spleno- 
cytes. Mitochondria were purified from control splenocytes (co.) or from 
splenocytes exposed to  the  glucocorticoid DEX  in vivo,  followed by 
staining with DiOCt(3).  (B) Mitochondria from apoptotic splenic lym- 
phocytes induce nuclear apoptosis. Mitochondria from control or DEX- 
primed splenocytes  were mixed with HeLa nuclei either in the absence or 
in the presence of BA to assess their apoptosis-inducing potential as in 
Fig. 4 B. Splenic mitochondria were tested at a concentration of 250 ng/ 
I*1. Typical results out of three independent experiments are shown. 
apoptotic  cascade  in  vivo  and  that  mitochondrial  PT  is 
both sufficient and necessary to induce nuclear apoptosis. 
Bcl-2  Inhibits  Apoptosis  by  Preventing Mitochondrial  PT. 
The  proto-oncogene  product  Bcl-2  inhibits  apoptosis  in 
response to a  number of different stimuli (for a  review see 
reference 54)  and prevents both the mitochondrial and the 
nuclear manifestations of apoptosis (12).  Bcl-2 is localized 
in  the  mitochondrial outer  membrane  and  endoplasmatic 
reticulum, as well as in nuclear membranes (55-57). Within 
the  mitochondrion,  it  is  found  at  the  inner-outer  mem- 
brane  contact site, where  PT  pores  are  expected  to  form 
(20).  To  map the antiapoptotic function of Bcl-2 either to 
mitochondria  or  to  nuclei,  we  purified  these  organelles 
from  hBcl-2-transfected  murine  T  cell  hybridoma  cells 
(39),  as well as from mock-transfected controls. R.econsti- 
tution  experiments  indicate  that  Atr-treated mitochondria 
8om hBcl-2-transfected cells fail to provoke nuclear apoptosis 
(Fig. 7  A) in conditions in which mitochondria from vec- 
tor-transfected cells (Fig. 7  A) or from hepatocytes consti- 
tutively lacking Bcl-2 expression (Figs. 1 and 3) do induce 
nuclear  apoptosis.  In  contrast,  nuclei  from  hBcl-2-trans- 
fected cells readily condense and fragment in the presence 
of  Atr and control mitochondria (Fig. 7, A  and B). Thus, in 
accord  with  previous  genetic  (55,  57)  and  functional  (4) 
studies, the mitochondrial but not the  nuclear localization 
of Bcl-2 is critical for its antiapoptotic function.  In control 
experiments, mixtures of Bcl-2-transfected and control mi- 
tochondria induce apoptosis (Fig. 7  A), indicating that the 
Bcl-2-mediated inhibition of apoptosis acts in cis and can- 
not be attributed to cytosolic Bcl-2 contaminating the mi- 
tochondrial preparation. In addition, isolated mitochondria 
from  Bcl-2-transfected  cells  are  protected  against  Atr- 
induced  PT,  i.e.,  they  fail  to  undergo  large  amplitude 
swelling and A~ m disruption in response to Atr (Fig. 7,  C 
and D). Bcl-2 is a potent inhibitor of some death pathways, 
including  pro-oxidants  (58),  but  is  comparatively  ineffi- 
cient in preventing calcium-induced and antigen receptor- 
mediated PCD  (38,  39,  59).  We  therefore tested whether 
Bcl-2  would  be  a  universal  inhibitor  of  PT  or  rather, 
whether it would have a selective effect. As shown in Fig. 8 
A, Bcl-2 prevents large amplitude swelling of isolated mi- 
tochondria in response to M-C1CCP and ter-BHP, but not 
in response to  calcium or diamide. These  data underscore 
that different PT  inducers obey different mechanisms;  this 
is  also  suggested  by  experiments  involving  PT  inhibitors 
1538  Mitochondrial Regulation of Apoptosis Figure  7.  Mechanism of the antiapoptotic effect of Bcl-2.  (A) Functional mapping of the site at which Bcl-2 acts to prevent Atr-induced apoptosis. 
Nuclei and mitochondria from Bcl-2- or Neo-transfected  cells were cocultured in the presence or absence of  Atr (5 raM), as indicated by black squares. 
After 90 rain ofcoculture, nuclei were stained with DAPI and analyzed for apoptotic morphology. (B) Representative nuclei from Bcl-2-transfected cells 
incubated with the indicated type of mitochondria and/or Atr (same experiment as A). (C) Bcl-2 directly inhibits the Atr-induced large amplitude swell- 
ing ofmitochondria. Mitochondria from Neo- or Bcl-2-transfected  cells were monitored for large amplitude swelling (as in Fig. 1 A). (Arrows) Repeated 
addition of 2.5 mM Atr (final concentration 5 raM). (D) Bcl-2 inhibits the Atr-induced disruption of the mitochondrial transmembrane potential. Mito- 
chondria were labeled with DiOC6(3), cultured for 5 min in the presence or absence of 5 mM Atr, and were then analyzed by cytofluorometry. 
(Fig.  3).  The  pattern  of the  bcl-2  effect  corresponds  most 
closely  to  that  of BA,  i.e.,  it inhibits PT  induced  by Atr 
(Figs.  3  and 7),  m-C1CCP,  and ter-BHP, but not calcium 
or diamide (Figs. 3  and 8). Again, as in the case ofBA, Bcl- 
2-mediated inhibition of PT results in the abolition of the 
apoptotic potential of isolated mitochondria.  More impor- 
tantly, the Bcl-2-driven inhibition of mitochondrial swell- 
ing  (Fig.  8  A)  correlates  with  its  apoptosis-inhibitory po- 
tential in  cells.  Bcl-2  protects  against  apoptosis  of T  cell 
hybridoma cells induced by m-C1CCP  (Fig. 8  B)  and oxi- 
dants  such  as  H202  (58),  yet  fails  to  confer  protection 
against diamide  (Fig.  8  /3)  and CD3  cross-linking (12,  38, 
39).  Thus, Bcl-2 does not prevent apoptosis when death is 
induced via such agents as diamide (Fig. 8  B) against whose 
PT-inducing potential it does not protect (Fig. 8 A). Again, 
these data are in accord with the hypothesis that Bcl-2 pre- 
vents apoptosis by virtue of its PT-inhibitory potential. 
A  Soluble Factor Released  from Mitochondria Undergoing PT 
Mediates Nuclear Disintegration.  As shown above, mitochon- 
dria undergoing PT induce apoptotic nuclear disintegration 
in  a  cell-free  system.  Whereas  some  authors  have  shown 
that mitochondria are necessary to induce apoptosis in cell- 
free  systems  (4,  60),  others  have  found that  cytosolic  (or- 
ganelle-free)  extracts  may be  suflficient to  induce  nuclear 
Ali  mCICCP  _.~u~[~._~  t-BHP 
o  3o ~  9o~2otso~so o  3o ~  ~t2otsmso o  3o ,o 9o~z.~so~so o  3o.  ~12.~.~. 
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Figure 8.  Correlation of the antiapoptotic and the PT-inhibitory  effect ofBcl-2. (A) Effect of  Bcl-2 on large amplitude swelling of  isolated rnitochon- 
dria. (Arrows) The indicated reagents were added (same concentrations as in Fig. 3), while absorbance at 540 nm was monitored.  (B) Spectrum of  Bcl-2- 
mediated inhibition of apoptosis in whole cells. Bcl-2, or Neo-transfected  T cell hybridoma cells were cultured with the indicated dose ofmC1CCP pr 
diamide for 6 or 24 h, respectively. The percentage of cells with nuclear hypoploidy was determined after ethanol fixation and staining with propidium 
iodine. 
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Figure  9.  Partial characterization of a proapoptotic  activity released 
from Atr-treated mitochondria. Liver mitochondria were incubated in the 
presence  or  absence of 5  mM  Atr, followed  by  ultracentrifugation 
(150,000 g, 30 min). Isolated HeLa nuclei were incubated in the presence 
of this supernatant to determine the frequency of cells exhibiting apop- 
totic morphology (90 rain, 37~  Supernatants were heat treated (70~ 
5 min) or centrifuged through membranes with a molecular mass exclu- 
sion of~10 kD before the test. Alternatively, the antioxidants N-t-butyl- 
a-phenylnitrone  (50 p.M), trolox (230 I~M), L-ascorbate (600 I~M), or 
catalase (1 mg/ml) were added to the assay. 
apoptosis in vitro  (5, 42).  Prompted by this  apparent  con- 
tradiction, we tested whether mitochondria undergoing PT 
would  release  a  soluble  proapoptotic  factor.  As  shown  in 
Fig.  9,  mitochondria  treated  with  Atr  release  (a)  soluble 
factor(s) into  the  supernatant  (150,000 g, 30  rain)  that can 
induce  chromatin  condensation  in  isolated  HeLa  nuclei. 
This activity is heat sensitive (70~  5 rain), has a molecular 
mass >10  kD,  and is not  neutralized  by antioxidants  such 
as  N-t-butyl-cx-phenylnitrone  or  the  water-soluble  vita- 
mine E  analogue trolox (Fig. 9). In conclusion,  at least part 
of the  apoptotic  activity  of mitochondria  is  mediated  by 
one  or  several  proteins  and  does  not  involve  R.OS.  PT- 
dependent  release of proteins from mitochondria  has been 
reported previously (61). 
Concluding  Remarks 
As shown in this article, mitochondria from hepatic, my- 
elomonocytic,  or lymphoid  cells induce  nuclear  apoptosis, 
provided that they undergo  PT.  Modulation  of PT deter- 
mines  the  apoptosis-inducing  effect  of mitochondria  in  a 
cell-free system. Moreover, inhibition  of PT by BA, a spe- 
cific ligand  of one  PT  pore  constituent,  reduces  naturally 
occurring  apoptosis,  and  Bcl-2  apparently  functions  as  an 
endogenous PT inhibitor.  Although these findings establish 
mitochondrial PT as a critical event in early apoptosis, they 
do  not  resolve a  number  of issues  concerning  the  cellular 
biology of apoptosis. 
According to studies performed in Caenorhabditis elegans, 
at least two gene products, ced-3, which encodes a cysteine 
protease,  and  ced-4,  whose  function  is unknown,  are  re- 
quired for apoptosis to occur (62). At present, the sequence 
of events that eventually link ced-3-like proteases and ced-4 
to  mitochondria  remains  unknown.  At present,  it appears 
clear  that  both  Bcl-2  (which  controls  PT;  Figs.  7  and  8) 
and  protease  activation  control  two  checkpoints  of the 
apoptotic cascade (63). Tetrapeptide inhibitors of the ced-3 
homologue CPP32/Yama  and of ICE fail to interfere with 
the  induction  of PT  in isolated  mitochondria.  Moreover, 
they fail to inhibit the mitochondria-mediated induction  of 
nuclear  apoptosis  (Table  1). When  thymocyte apoptosis is 
induced by Fas/CD95 cross-linking, inhibition of ICE pre- 
vents both the  nuclear manifestations  of apoptosis and the 
A~r~  disruption  (Marchetti,  P.,  and  G.  Kroemer,  unpub- 
lished  results).  This  may indicate  that at least some  of the 
members  of the  family  of  ced-3-1ike  proteases  regulate 
events that are upstream of mitochondria. At present, how- 
ever,  our data  cannot  distinguish  between  two  alternative 
possibilities.  First, the PT and the protease-regulated check- 
points of the  apoptotic effector phase could be placed in a 
serial  (hierarchical)  fashion.  Second,  both protease  activa- 
tion and PT could form part of parallel pathways culminat- 
ing in nuclear apoptosis. 
It remains largely unknown  how Bcl-2 regulates  PT on 
the molecular level. Bcl-2 does not prevent PT as such;  it 
prevents the induction  of PT by determined stimuli such as 
Atr,  mC1CCP,  and  ter-BHP,  but  not  calcium  or  diamide 
(Figs. 7  and 8). Bcl-2 could act via direct molecular associ- 
ation with constituents  of the PT pore, a possibility that is 
suggested  by  the  localization  of both  Bcl-2  and  PT  pore 
constituents  at  inner-outer  membrane  contact  sites  (55- 
57). Alternatively, Bcl-2 could affect PT indirectly. Thus, it 
enhances  oxidative  phosphorylation  (64)  and  causes mito- 
chondrial  inner  membrane  hyperpolarization  (65),  which 
in turn would reduce the probability of PT (24). It has pre- 
viously been reported that mitochondrial membrane local- 
ization is necessary to mediate Bcl-2 suppression ofapopto- 
sis,  namely  when  apoptosis  is  induced  by  EIB-defective 
adenovirus  (57)  and when it is triggered by IL-3 starvation 
of IL-3-dependent  32D  cells  (55).  In  contrast,  in  some 
other systems of apoptosis induction,  a mutated Bcl-2 mol- 
ecule lacking the membrane localization domain (4, 58), as 
well  as  the  naturally  occurring  apoptosis-inhibitory  Bcl-2 
analogue  Bcl-XATM  (a splice  variant  of Bcl-X  that lacks 
the  transmembrane  domain;  66),  maintain  their  antiapop- 
totic  potential.  However,  the  fact that soluble,  ubiquitous 
Bcl-2 still maintains at least part of a its antiapoptotic func- 
tion  does not formally exclude  that it acts on the  external 
membrane  of mitochondria.  The  present  data  suggest  an 
intimate linkage between Bcl-2 and mitochondrial  regula- 
tion.  In this context it may be intriguing that the C. etegans 
bcl-2 homologue, ced-9, is an element of a polycistronic lo- 
cus that  also  contains  cyt-1,  a  gene  that encodes  a  protein 
similar to  cytochrome  b560  of the  mitochondrial  respira- 
tory chain  complex II (67).  Thus both functional  and  ge- 
netic evidence link Bcl-2 to mitochondrial regulation.  Irre- 
spective of the exact molecular mechanism by which Bcl-2 
affects PT, the finding that Bcl-2 does inhibit PT, at least in 
response to certain stimuli  (Figs.  7  and 8), provides an ex- 
planation  for  hitherto  apparently  contradictory  reports. 
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duction  and/or  adverse  effects  of 1LOS  (58,  68),  that  in 
turn,  however, are not obligatory for apoptosis (16). In ac- 
cord with these findings,  Bcl-2 prevents oxidant-mediated 
PT (Fig. 8). Moreover, it prevents the mitochondrial ROS 
formation  that  is  secondary  to  PT  (12).  Thus,  Bcl-2  im- 
pedes PT as well as two dissociable consequences ofPT:  (a) 
nuclear  apoptosis,  and  (b)  mitochondrial  uncoupling  and 
superoxide anion generation. 
A  further issue that remains to be elucidated  is the mo- 
lecular mechanism by which  isolated mitochondria  under- 
going PT cause nuclear chromatin condensation  and endo- 
nuclease  activation.  It appears clear that this  mechanism is 
neither cell type nor species specific, given that, for example, 
mouse liver mitochondria in PT can promote the apoptotic 
disintegration  of nuclei purified from human fibroblast-like 
nuclei (Fig.  1). Our data indicate that mitochondria contain 
or  are  associated  with  (a)  pre-formed  soluble  mediator(s) 
>10kD  that is/are  released after PT  and  that  alone  is/are 
sufficient to cause nuclear apoptosis (Fig. 9). In accord with 
published  experiments  performed  on  intact  cells  (16,  17), 
antioxidants  do  not  neutralize  this  apoptosis  inducer  (Fig. 
9).  Thus,  ROS  that are formed by mitochondria  after PT 
do not participate in the induction of nuclear apoptosis; this 
is also indicated by experiments involving p~ cells that lack 
a functional respiratory chain (15, and Fig. 2). Moreover, it 
appears improbable that Ced-3-like proteases would be re- 
sponsible for this apoptosis-inducing activity, given that the 
mammalian Ced-3  analogue CPP32  per se is not sufficient 
to induce  nuclear apoptosis in a cell-free system (6).  Thus, 
the  molecular  events  linking  mitochondrial  PT  to  nuclear 
apoptosis await further characterization. 
From the  available data,  it appears that  AXI/m disruption, 
which  presumably is mediated by PT, is a  constant feature 
of early apoptosis (8-14).  Indirect biochemical evidence has 
previously accused PT to participate in the postischemic or 
toxin-mediated  death  of myocardial  cells  and  hepatocytes 
(69-72), thus again suggesting that PT is a general regulator 
of cell death.  Indeed, the PT pore is an attractive candidate 
for a death switch that, once activated, marks a point of no 
return  in  PCD.  At  least  six reasons  support  this  concept. 
First,  as shown here, PT is both necessary and sufficient to 
cause nuclear  apoptosis.  Second,  opening of PT pores en- 
tails  multiple potentially lethal  alterations  of mitochondrial 
function  (loss of A~ m, uncoupling of the respiratory chain, 
hypergeneration  of ROS,  and  loss  of mitochondrial  glu- 
tathione  and  calcium;  12,  19-21)  and  thus  may  initiate 
pleiotropic  death pathways.  Moreover,  as shown here,  PT 
triggers  a  nuclear  apoptosis  effector  pathway  whose  bio- 
chemical components  remain  elusive.  Third,  the  PT pore 
functions as a sensor for multiple physiological effectors (di- 
valent  cations,  ATP,  ADP,  NAD,  A@m,  pH,  thiols,  and 
peptides),  thereby  integrating  information  on  the  electro- 
physiological, redox, and metabolic state of the cell (19, 20, 
73,  and  Fig.  3).  Thus,  different  death  inducers  can  con- 
verge at this level. Fourth,  given that a PT pore constituent 
such as the ANT is essential for energy metabolism, muta- 
tions in this  apoptosis-regulatory  device will be mostly le- 
thal for the  cell.  In teleological terms, this would have the 
advantage  of precluding  apoptosis-inhibitory  (oncogenic) 
mutations  at  this  level  of the  apoptotic  cascade.  Fifth,  at 
least one  of the  PT  constituents,  the ANT,  is encoded by 
several  members  of a  gene  family that  are  expressed  in  a 
strictly tissue-specific manner (74). Thus, PT pores may be 
regulated  in  each  cell  type  in  a  slightly  different  fashion. 
Sixth,  PT is endowed  with self-amplificatory properties  in 
the sense that loss of matrix Ca  2+ and glutathione,  depolar- 
ization of the inner membrane,  and increased  oxidation of 
thiols, that result from PT pore opening, all increase the PT 
pore-gating  potential  (19-21,  23-29).  The  self-amplifica- 
tory  property  of PT  is also  underscored  by the  data  pre- 
sented  in  this  paper.  Thus,  induction  of PT  induces  A~m 
disruption (Figs.  1 and 7) and, conversely, AxIf  m depolariza- 
tion  by mC1CCP  causes PT,  measured  as large  amplitude 
swelling (Figs. 3 and 8). Similarly, oxidant treatment causes 
PT (Figs. 3 and 8), and PT will ultimately entail mitochon- 
drial  generation  of tLOS  (12).  The  fact that  some  conse- 
quences  of PT  (e.g.,  AW  m dissipation,  ROS  generation) 
themselves may cause PT suggests that PT may engage in a 
positive  feedback  loop  that  contributes  to  apoptotic  au- 
todestruction.  Thus,  PT would have to respond  in an all- 
or-nothing  fashion  and,  once  activated,  would  seal  the 
cell's fate in an  irreversible  fashion.  Accordingly,  cells ex- 
hibiting an immediate consequence  of PT, that is AXI'?  m re- 
duction,  are irreversibly committed to cell death (10). 
Apart from these  theoretical  considerations,  the  current 
data suggest that the PT pore occupies a central position in 
apoptosis regulation.  It therefore becomes an attractive tar- 
get for regulation  by pharmacological  agents,  as well as by 
endogenous  apoptosis  regulators  belonging  to  the  ever- 
expanding Bcl-2 gene family. 
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